Skip to content
OpenCapital
Get started
Twist Bioscience Corporation logo

Twist Bioscience Corporation (TWST) Q1 2026 Earnings

TWST·Reported May 4, 2026·Before market open

Twist Bioscience Corporation reported Q1 2026 revenue of $110.7M (+19.3% YoY), beat analyst consensus of $107.6M by $3.1M. Diluted EPS came in at $-0.62 (+6.1% YoY), missed the $-0.49 consensus by $0.13.

Revenue
$110.7Mbeat by $3.1M
Consensus: $107.6M
Diluted EPS
$-0.62missed by $0.13
Consensus: $-0.49
SEC

SEC Filings

Earnings release8-K · 0001581280-26-000037
Quarterly report10-Q · 0001581280-26-000040

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Twist Bioscience Corporation's Q1 2026 earnings report.

Twist Bioscience Corporation (TWST) reported Q1 2026 earnings on May 4, 2026 before market open.

Twist Bioscience Corporation reported revenue of $110.7M and diluted EPS of $-0.62 for Q1 2026.

Revenue beat the consensus estimate of $107.6M by $3.1M. EPS missed the consensus estimate of $-0.49 by $0.13.

Compared to the same quarter a year prior, revenue grew 19.3% from $92.8M a year earlier and diluted EPS grew 6.1% from $-0.66.

You can read the 8-K earnings release (0001581280-26-000037) and the 10-Q periodic report (0001581280-26-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.